Expert Opinion on Emerging Drugs, pages 1-5

Muscarinic M1 and M4 agents as treatments for schizophrenia: what do they do and who do they do it for?

Philip D. Harvey ^{1, 2}

University of Miami MIller School of Medicine, MIami, FL |

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA |

Publication type: Journal Article

Publication date: 2025-01-23

Taylor & Francis

Journal: Expert Opinion on Emerging Drugs

scimago Q1

wos Q2

SJR: 0.881

CiteScore: 5.9

Impact factor: 2.7

ISSN: 14728214, 17447623

DOI: 10.1080/14728214.2025.2458053

Copy DOI

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex

Found error?

Publisher

Taylor & Francis

Journal

scimago Q1

wos Q2

SJR

0.881

CiteScore

5.9

Impact factor

2.7

ISSN

14728214 (Print)

17447623 (Electronic)